About Labwater
Labwater is a publicly listed company based in India. It offers lab water purification products and services for various sectors. It operates on a B2B model. The company has 2,253 employees. Its Indian entity Ion Exchange (India) Limited reported revenue of βΉ3,003 Cr. Labwater offers products and services including Lab-Q Ultra, Lab-Q Smart, Lab-Q Water Maker, and Lab-Q Spectra. Its focus areas include Industrial Tech, Water Treatment, Environmental Solutions and Laboratory Applications.
Company details
Ion Exchange (India) Ltd. specializes in water and environment management, providing purification systems for laboratories. They design, supply, and install technologies for pure and ultrapure water in biomedical, clinical, and industrial applications. Based in Mumbai, India, the company serves clients like IIT Roorkee and UAE institutions, ensuring compliance with international standards through innovative, cost-effective solutions.
- Headquarters India
- Employees 2,253
- Stage Public
- SectorsChemicals & Materials
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website labwater.in
- Social LinkedIn
- Legal Name Ion Exchange (India) Ltd
- Date of Incorporation 06 Mar, 1964
- Jurisdiction Mumbai, Maharashtra, India
- Market Cap₹4,879 Cr
IONEXCHANG · NSE
- Share Price₹340.10
+2.24% today
- Revenue₹2,915 Cr
FY 2025-26 · +6.5% YoY
- EBITDA₹197 Cr
Margin 6.8%
- Net Profit₹153 Cr
FY 2025-26 · -26.1% YoY
- P/E (TTM)45.0x
P/B 3.7x
- ROE11.2%
ROCE 13.0%
- Debt / Equity0.32
Interest cover 20.5x
- Employee Count2,253
Associated legal entities of Labwater
Labwater operates through Ion Exchange (India) Limited, a listed company (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2026) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Ion Exchange (India) Limited Listed CIN L74999MH1964PLC014258 | Active | 06 Mar 1964 | Mumbai, Maharashtra | ₹3,003 Cr | 2,253 | 13 | View details |
Products & Services of Labwater
Labwater offers a comprehensive portfolio of products and services, including Lab-Q Ultra, Lab-Q Smart, Lab-Q Water Maker, and Lab-Q Spectra.
Delivers pure water for routine and critical lab applications
Generates reagent grade water for laboratory use
Provides instant water as alternative to distillation units
Offers ultrapure water for advanced lab instruments
Apps and channels of Labwater
Labwater publishes 1 mobile app with over 10K+ downloads.
Board of directors of Ion Exchange (India) Limited (Labwater)
Ion Exchange (India) Limited is the primary company behind Labwater. The board of Ion Exchange (India) Limited currently have 10 directors; the longest-serving is Rajesh Chandrabhan Sharma, appointed in 1996. 12 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Rajesh Chandrabhan Sharma DIN 00515486 | Whole-time director | 26 Mar 1996 | 30 yrs 7 mo | Ion Exchange (India) Limited |
| Mahabir Prasad Patni DIN 00515553 | Director | 28 Sep 2001 | 25 yrs | Ion Exchange (India) Limited |
| Aankur Patni DIN 00090657 | Director | 24 Jan 2006 | 20 yrs 9 mo | Ion Exchange (India) Limited |
| Dinesh Sharma DIN 00051986 | Director | 24 Jan 2006 | 20 yrs 9 mo | Ion Exchange (India) Limited |
| David Paul Rasquinha DIN 01172654 | Director | 02 Aug 2022 | 4 yrs 2 mo | Ion Exchange (India) Limited |
| Sanjay Vithalrao Joshi DIN 01656787 | Director | 26 Jul 2023 | 3 yrs 3 mo | Ion Exchange (India) Limited |
| Padmanabhan Gopalaraman DIN 07130908 | Director | 02 Aug 2024 | 2 yrs 2 mo | Ion Exchange (India) Limited |
| Alka Arora Misra DIN 08038518 | Director | 02 Aug 2024 | 2 yrs 2 mo | Ion Exchange (India) Limited |
| Amitava Guharoy DIN 10708866 | Director | 02 Aug 2024 | 2 yrs 2 mo | Ion Exchange (India) Limited |
| Indraneel Dutt DIN 01942447 | Managing Director | 01 Oct 2024 | 2 yrs | Ion Exchange (India) Limited |
IPO & Listings of Labwater
Labwater is a publicly listed company on the NSE with ticker symbol IONEXCHANG in India, operating in the Infrastructure Developers & Operators sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- Listed onNSE: IONEXCHANG
- Listed entityIon Exchange (India) Limited
- Exchange sectorInfrastructure Developers & Operators
Financials of Labwater
Exchange-reported figures of Ion Exchange (India) Limited, the listed company behind Labwater (NSE: IONEXCHANG).
Financial Highlights
FY 2025-26 Β· ConsolidatedRevenue vs Net Profit ₹ Cr
Margin trends
Financial summary ₹ Cr
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 2,915 | 2,737 | 2,348 | 1,990 | 1,577 | 1,450 | 1,480 |
| Revenue growth | +6.5% | +16.6% | +18.0% | +26.2% | +8.8% | -2.1% | - |
| EBITDA | 197 | 297 | 275 | 258 | 216 | 204 | 138 |
| EBITDA margin | +6.8% | +10.9% | +11.7% | +13.0% | +13.7% | +14.1% | +9.3% |
| Profit before tax | 195 | 285 | 269 | 259 | 217 | 195 | 131 |
| Net profit | 153 | 208 | 196 | 197 | 163 | 146 | 93.69 |
| Net profit margin | +5.3% | +7.6% | +8.3% | +9.9% | +10.3% | +10.1% | +6.3% |
| EPS (βΉ) | 10.03 | 14.61 | 13.78 | 138.27 | 114.40 | 101.16 | 65.80 |
| Balance sheet | |||||||
| Total assets | 1,865 | 1,566 | 1,213 | 928 | 738 | 594 | 514 |
| Net worth | 1,339 | 1,208 | 1,018 | 833 | 656 | 506 | 363 |
| Total debt | 482 | 323 | 152 | 59.23 | 55.22 | 62.32 | 122 |
| Cash & bank | 319 | 466 | 588 | 548 | 536 | 505 | 373 |
| Net working capital | 850 | 768 | 723 | 616 | 460 | 344 | 261 |
| Cash flow | |||||||
| Cash from operations | (28.47) | 32.05 | 130 | 62.73 | 91.38 | 197 | 102 |
| Cash from investing | (36.38) | (165) | (160) | (41.14) | (92.67) | (26.58) | (17.34) |
| Cash from financing | 100 | 128 | 8.36 | (15.31) | (26.86) | (74.70) | (28.17) |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 700 | 863 | 734 | 734 | 583 | 835 | 691 | 644 |
| Revenue growth (YoY) | +20.1% | +3.4% | +6.4% | +13.9% | +2.8% | - | - | - |
| Other income | 6.36 | 43.13 | 12.54 | 14.62 | 18.20 | 14.84 | 8.91 | 14.53 |
| EBITDA | 31.74 | 19.74 | 42.28 | 68.49 | 62.54 | 85.74 | 75.47 | 68.30 |
| EBITDA margin | +4.5% | +2.3% | +5.8% | +9.3% | +10.7% | +10.3% | +10.9% | +10.6% |
| Depreciation | 21.75 | 19.60 | 18.57 | 12.17 | 12.26 | 11.83 | 11.33 | 10.89 |
| Interest | 8.95 | 10.79 | 7.57 | 3.08 | 2.56 | 3.61 | 3.30 | 3.62 |
| Profit before tax | 7.40 | 32.48 | 28.68 | 67.86 | 65.92 | 85.14 | 69.75 | 68.32 |
| Tax | 4.34 | 8.19 | 8.12 | 17.94 | 17.48 | 21.90 | 20.16 | 17.68 |
| Net profit | 3.06 | 24.29 | 20.56 | 49.92 | 48.44 | 63.24 | 49.59 | 50.64 |
| EPS (βΉ) | 0.35 | 2.04 | 1.71 | 4.18 | 4.11 | 5.34 | 4.10 | 4.30 |
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 2,679 | 2,540 | 2,180 | 1,892 | 1,509 | 1,402 | 1,407 |
| Revenue growth | +5.5% | +16.5% | +15.2% | +25.4% | +7.7% | -0.4% | - |
| EBITDA | 173 | 288 | 270 | 240 | 199 | 197 | 124 |
| EBITDA margin | +6.4% | +11.3% | +12.4% | +12.7% | +13.2% | +14.1% | +8.8% |
| Profit before tax | 187 | 288 | 274 | 246 | 209 | 196 | 134 |
| Net profit | 148 | 214 | 204 | 185 | 154 | 146 | 99.19 |
| Net profit margin | +5.5% | +8.4% | +9.4% | +9.8% | +10.2% | +10.4% | +7.1% |
| EPS (βΉ) | 9.43 | 14.62 | 13.92 | 126.23 | 105.14 | 99.53 | 67.58 |
| Balance sheet | |||||||
| Total assets | 1,838 | 1,545 | 1,171 | 966 | 831 | 691 | 605 |
| Net worth | 1,390 | 1,270 | 1,074 | 887 | 767 | 627 | 482 |
| Total debt | 410 | 244 | 59.24 | 49.31 | 37.93 | 41.14 | 99.73 |
| Cash & bank | 271 | 424 | 535 | 517 | 513 | 487 | 354 |
| Net working capital | 819 | 721 | 699 | 615 | 513 | 389 | 304 |
| Cash flow | |||||||
| Cash from operations | (55.73) | 26.18 | 124 | 54.68 | 75.14 | 192 | 64.73 |
| Cash from investing | (30.15) | (169) | (161) | (22.78) | (81.17) | (25.49) | 6.55 |
| Cash from financing | 111 | 148 | (11.76) | (26.98) | (21.71) | (69.52) | (22.66) |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 636 | 814 | 669 | 678 | 518 | 785 | 650 | 589 |
| Revenue growth (YoY) | +22.7% | +3.7% | +2.9% | +15.2% | +0.3% | - | - | - |
| Other income | 13.24 | 44.70 | 14.25 | 16.48 | 19.52 | 15.15 | 10.76 | 12.61 |
| Total expenses | 605 | 803 | 627 | 617 | 462 | 702 | 576 | 522 |
| EBITDA | 30.68 | 11.08 | 41.73 | 60.77 | 56.21 | 83.28 | 74.43 | 66.95 |
| EBITDA margin | +4.8% | +1.4% | +6.2% | +9.0% | +10.9% | +10.6% | +11.5% | +11.4% |
| Depreciation | 20.34 | 18.38 | 17.21 | 10.96 | 11.03 | 10.66 | 10.21 | 9.77 |
| Interest | 8.21 | 10.07 | 6.64 | 2.17 | 1.66 | 2.53 | 2.05 | 2.14 |
| Profit before tax | 15.37 | 27.33 | 32.13 | 64.12 | 63.04 | 85.24 | 72.93 | 67.65 |
| Tax | 3.97 | 7.76 | 8.07 | 16.25 | 16.16 | 20.66 | 19.60 | 16.91 |
Financial Statements
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 700 | 863 | 734 | 734 | 583 | 835 | 691 | 644 |
| Revenue growth (YoY) | +20.1% | +3.4% | +6.4% | +13.9% | +2.8% | - | - | - |
| Other income | 6.36 | 43.13 | 12.54 | 14.62 | 18.20 | 14.84 | 8.91 | 14.53 |
| EBITDA | 31.74 | 19.74 | 42.28 | 68.49 | 62.54 | 85.74 | 75.47 | 68.30 |
| EBITDA margin | +4.5% | +2.3% | +5.8% | +9.3% | +10.7% | +10.3% | +10.9% | +10.6% |
| Depreciation | 21.75 | 19.60 | 18.57 | 12.17 | 12.26 | 11.83 | 11.33 | 10.89 |
| Interest | 8.95 | 10.79 | 7.57 | 3.08 | 2.56 | 3.61 | 3.30 | 3.62 |
| Profit before tax | 7.40 | 32.48 | 28.68 | 67.86 | 65.92 | 85.14 | 69.75 | 68.32 |
| Tax | 4.34 | 8.19 | 8.12 | 17.94 | 17.48 | 21.90 | 20.16 | 17.68 |
| Net profit | 3.06 | 24.29 | 20.56 | 49.92 | 48.44 | 63.24 | 49.59 | 50.64 |
| EPS (βΉ) | 0.35 | 2.04 | 1.71 | 4.18 | 4.11 | 5.34 | 4.10 | 4.30 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 2,915 | 2,737 | 2,348 | 1,990 | 1,577 | 1,450 | 1,480 |
| Revenue growth | +6.5% | +16.6% | +18.0% | +26.2% | +8.8% | -2.1% | - |
| Other income | 88.27 | 49.61 | 45.42 | 42.00 | 42.11 | 33.09 | 35.81 |
| Total expenses | 2,718 | 2,440 | 2,073 | 1,732 | 1,361 | 1,245 | 1,342 |
| Employee cost | 415 | 342 | 297 | 236 | 199 | 174 | 181 |
| EBITDA | 197 | 297 | 275 | 258 | 216 | 204 | 138 |
| EBITDA margin | +6.8% | +10.9% | +11.7% | +13.0% | +13.7% | +14.1% | +9.3% |
| Depreciation | 62.60 | 44.49 | 36.41 | 29.09 | 28.04 | 27.67 | 23.53 |
| Interest | 27.50 | 16.83 | 15.47 | 12.05 | 12.67 | 14.72 | 19.25 |
| Profit before tax | 195 | 285 | 269 | 259 | 217 | 195 | 131 |
| Tax | 51.73 | 77.23 | 73.54 | 63.74 | 55.64 | 51.71 | 36.73 |
| Net profit | 153 | 208 | 196 | 197 | 163 | 146 | 93.69 |
| Net profit margin | +5.3% | +7.6% | +8.3% | +9.9% | +10.3% | +10.1% | +6.3% |
| EPS (βΉ) | 10.03 | 14.61 | 13.78 | 138.27 | 114.40 | 101.16 | 65.80 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | 14.23 | 14.23 | 14.23 | 14.23 | 14.23 | 14.23 | 14.23 |
| Reserves & surplus | 1,325 | 1,194 | 1,004 | 819 | 670 | 520 | 377 |
| Shareholders' funds (net worth) | 1,339 | 1,208 | 1,018 | 833 | 656 | 506 | 363 |
| Minority interest | 1.29 | 1.61 | 1.90 | 2.31 | (0.83) | (0.12) | 2.03 |
| Secured loans | 452 | 301 | 136 | 51.90 | 41.97 | 43.86 | 96.75 |
| Unsecured loans | 29.75 | 21.38 | 16.79 | 7.33 | 13.25 | 18.46 | 25.42 |
| Total debt | 482 | 323 | 152 | 59.23 | 55.22 | 62.32 | 122 |
| Total liabilities | 1,865 | 1,566 | 1,213 | 928 | 738 | 594 | 514 |
| Assets | |||||||
| Gross block | 1,024 | 603 | 536 | 354 | 303 | 276 | 253 |
| Net block | 753 | 392 | 367 | 215 | 192 | 190 | 194 |
| Capital work in progress | 176 | 323 | 60.68 | 41.95 | 20.04 | 14.60 | 11.51 |
| Investments | 15.83 | 13.19 | 12.23 | 9.84 | 8.66 | 4.51 | 4.57 |
| Inventories | 441 | 299 | 237 | 222 | 181 | 128 | 134 |
| Sundry debtors | 1,075 | 1,107 | 935 | 697 | 508 | 449 | 502 |
| Cash & bank balances | 319 | 466 | 588 | 548 | 536 | 505 | 373 |
| Loans & advances | 521 | 308 | 191 | 161 | 122 | 111 | 120 |
| Total current assets | 2,356 | 2,180 | 1,950 | 1,628 | 1,347 | 1,193 | 1,129 |
| Total current liabilities | 1,506 | 1,412 | 1,227 | 1,011 | 887 | 849 | 868 |
| Net working capital | 850 | 768 | 723 | 616 | 460 | 344 | 261 |
| Total assets | 1,865 | 1,566 | 1,213 | 928 | 738 | 594 | 514 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | 149 | 154 | 175 | 169 | 197 | 101 | 45.17 |
| Net cash from operating activities | (28.47) | 32.05 | 130 | 62.73 | 91.38 | 197 | 102 |
| Net cash from investing activities | (36.38) | (165) | (160) | (41.14) | (92.67) | (26.58) | (17.34) |
| Net cash from financing activities | 100 | 128 | 8.36 | (15.31) | (26.86) | (74.70) | (28.17) |
| Net change in cash | 35.27 | (4.35) | (21.72) | 6.28 | (28.15) | 95.77 | 56.28 |
| Closing cash | 319 | 466 | 588 | 548 | 536 | 505 | 373 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | +6.5% | +16.6% | +18.0% | +26.2% | +8.8% | -2.1% | - |
| EBITDA growth | -33.8% | +7.9% | +6.8% | +19.4% | +5.7% | +48.2% | - |
| PBT growth | -31.7% | +6.2% | +3.9% | +19.0% | +11.4% | +49.0% | +28.5% |
| Net income growth | -26.1% | +6.0% | -0.6% | +21.1% | +11.6% | +55.6% | - |
| Revenue CAGR (3Y) | +13.6% | +20.2% | +17.4% | +10.4% | +10.7% | +11.5% | +13.6% |
| EBITDA CAGR (3Y) | -8.6% | +11.2% | +10.5% | +23.2% | +25.6% | +36.6% | +22.9% |
| Profitability & leverage | |||||||
| Net income margin | +4.9% | +7.6% | +8.3% | +9.8% | +10.3% | +9.9% | +6.4% |
| Return on capital employed | +13.0% | +21.8% | +26.6% | +32.5% | +34.5% | +37.9% | +33.2% |
| Return on net worth | +11.2% | +18.7% | +21.1% | +26.2% | +27.8% | +33.0% | +30.2% |
| Debt / equity | 0.32 | 0.21 | 0.11 | 0.08 | 0.10 | 0.21 | 0.37 |
| Long-term debt / equity | 0.25 | 0.17 | 0.08 | 0.02 | 0.02 | 0.05 | 0.09 |
| Interest cover | 20.50 | 6.66 | 6.47 | 5.27 | 6.74 | 8.33 | 16.84 |
| Efficiency & per share | |||||||
| Fixed asset turnover | 3.58 | 4.81 | 5.27 | 6.05 | 5.44 | 5.48 | 6.48 |
| Inventory turnover | 7.87 | 10.22 | 10.23 | 9.87 | 10.22 | 11.06 | 11.20 |
| Debtors turnover | 2.67 | 2.68 | 2.88 | 3.30 | 3.30 | 3.05 | 3.20 |
| EPS (βΉ) | 10.03 | 14.61 | 13.78 | 138.27 | 114.40 | 101.16 | 65.80 |
| Dividend per share (βΉ) | 1.25 | 1.50 | 1.50 | 12.50 | 10.00 | 10.00 | 6.00 |
| Book value per share (βΉ) | 94.11 | 84.89 | 71.54 | 585.78 | 480.57 | 375.27 | 274.96 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 636 | 814 | 669 | 678 | 518 | 785 | 650 | 589 |
| Revenue growth (YoY) | +22.7% | +3.7% | +2.9% | +15.2% | +0.3% | - | - | - |
| Other income | 13.24 | 44.70 | 14.25 | 16.48 | 19.52 | 15.15 | 10.76 | 12.61 |
| Total expenses | 605 | 803 | 627 | 617 | 462 | 702 | 576 | 522 |
| EBITDA | 30.68 | 11.08 | 41.73 | 60.77 | 56.21 | 83.28 | 74.43 | 66.95 |
| EBITDA margin | +4.8% | +1.4% | +6.2% | +9.0% | +10.9% | +10.6% | +11.5% | +11.4% |
| Depreciation | 20.34 | 18.38 | 17.21 | 10.96 | 11.03 | 10.66 | 10.21 | 9.77 |
| Interest | 8.21 | 10.07 | 6.64 | 2.17 | 1.66 | 2.53 | 2.05 | 2.14 |
| Profit before tax | 15.37 | 27.33 | 32.13 | 64.12 | 63.04 | 85.24 | 72.93 | 67.65 |
| Tax | 3.97 | 7.76 | 8.07 | 16.25 | 16.16 | 20.66 | 19.60 | 16.91 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 2,679 | 2,540 | 2,180 | 1,892 | 1,509 | 1,402 | 1,407 |
| Revenue growth | +5.5% | +16.5% | +15.2% | +25.4% | +7.7% | -0.4% | - |
| Other income | 94.95 | 51.15 | 47.04 | 45.01 | 46.13 | 36.78 | 48.54 |
| Total expenses | 2,506 | 2,252 | 1,910 | 1,652 | 1,310 | 1,205 | 1,283 |
| Employee cost | 332 | 275 | 242 | 196 | 164 | 141 | 149 |
| EBITDA | 173 | 288 | 270 | 240 | 199 | 197 | 124 |
| EBITDA margin | +6.4% | +11.3% | +12.4% | +12.7% | +13.2% | +14.1% | +8.8% |
| Depreciation | 57.58 | 39.99 | 32.95 | 28.13 | 26.78 | 26.14 | 22.05 |
| Interest | 23.36 | 11.28 | 9.72 | 11.48 | 9.86 | 11.76 | 16.09 |
| Profit before tax | 187 | 288 | 274 | 246 | 209 | 196 | 134 |
| Tax | 48.24 | 73.53 | 70.25 | 60.66 | 54.53 | 49.90 | 35.06 |
| Net profit | 148 | 214 | 204 | 185 | 154 | 146 | 99.19 |
| Net profit margin | +5.5% | +8.4% | +9.4% | +9.8% | +10.2% | +10.4% | +7.1% |
| EPS (βΉ) | 9.43 | 14.62 | 13.92 | 126.23 | 105.14 | 99.53 | 67.58 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | 14.67 | 14.67 | 14.67 | 14.67 | 14.67 | 14.67 | 14.67 |
| Reserves & surplus | 1,375 | 1,256 | 1,060 | 872 | 781 | 640 | 495 |
| Shareholders' funds (net worth) | 1,390 | 1,270 | 1,074 | 887 | 767 | 627 | 482 |
| Secured loans | 384 | 227 | 47.23 | 42.77 | 21.50 | 23.21 | 76.86 |
| Unsecured loans | 25.65 | 17.12 | 12.01 | 6.54 | 16.43 | 17.93 | 22.87 |
| Total debt | 410 | 244 | 59.24 | 49.31 | 37.93 | 41.14 | 99.73 |
| Total liabilities | 1,838 | 1,545 | 1,171 | 966 | 831 | 691 | 605 |
| Assets | |||||||
| Gross block | 887 | 487 | 425 | 336 | 281 | 254 | 231 |
| Net block | 637 | 290 | 263 | 204 | 177 | 174 | 177 |
| Capital work in progress | 175 | 322 | 60.73 | 41.95 | 20.04 | 14.60 | 11.51 |
| Investments | 87.48 | 85.95 | 84.77 | 59.41 | 64.28 | 62.71 | 62.15 |
| Inventories | 386 | 241 | 189 | 186 | 146 | 102 | 118 |
| Sundry debtors | 1,073 | 1,099 | 922 | 697 | 509 | 453 | 514 |
| Cash & bank balances | 271 | 424 | 535 | 517 | 513 | 487 | 354 |
| Loans & advances | 512 | 303 | 213 | 183 | 181 | 151 | 150 |
| Total current assets | 2,241 | 2,067 | 1,859 | 1,583 | 1,349 | 1,193 | 1,135 |
| Total current liabilities | 1,422 | 1,346 | 1,160 | 968 | 836 | 804 | 832 |
| Net working capital | 819 | 721 | 699 | 615 | 513 | 389 | 304 |
| Total assets | 1,838 | 1,545 | 1,171 | 966 | 831 | 691 | 605 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | 116 | 110 | 159 | 154 | 181 | 84.61 | 36.00 |
| Net cash from operating activities | (55.73) | 26.18 | 124 | 54.68 | 75.14 | 192 | 64.73 |
| Net cash from investing activities | (30.15) | (169) | (161) | (22.78) | (81.17) | (25.49) | 6.55 |
| Net cash from financing activities | 111 | 148 | (11.76) | (26.98) | (21.71) | (69.52) | (22.66) |
| Net change in cash | 25.32 | 5.43 | (48.23) | 4.92 | (27.73) | 96.68 | 48.61 |
| Closing cash | 271 | 424 | 535 | 517 | 513 | 487 | 354 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | +5.5% | +16.5% | +15.2% | +25.4% | +7.7% | -0.4% | - |
| EBITDA growth | -40.1% | +6.7% | +12.3% | +20.7% | +1.1% | +59.2% | - |
| PBT growth | -35.2% | +5.0% | +11.6% | +17.8% | +6.6% | +46.0% | +32.7% |
| Net income growth | -31.1% | +5.0% | +10.0% | +20.3% | +5.5% | +47.2% | - |
| Revenue CAGR (3Y) | +12.3% | +19.0% | +15.9% | +10.4% | +11.0% | +12.5% | +15.0% |
| EBITDA CAGR (3Y) | -10.5% | +13.1% | +11.1% | +24.8% | +28.8% | +39.3% | +16.5% |
| Profitability & leverage | |||||||
| Net income margin | +5.2% | +8.4% | +9.4% | +9.8% | +10.2% | +10.4% | +7.0% |
| Return on capital employed | +12.4% | +22.0% | +26.6% | +28.6% | +28.7% | +32.0% | +27.7% |
| Return on net worth | +10.4% | +18.3% | +20.8% | +22.4% | +22.1% | +26.3% | +23.2% |
| Debt / equity | 0.25 | 0.13 | 0.06 | 0.05 | 0.06 | 0.13 | 0.22 |
| Long-term debt / equity | 0.20 | 0.11 | 0.04 | 0.02 | 0.02 | 0.04 | 0.06 |
| Interest cover | 20.30 | 4.55 | 4.10 | 5.41 | 5.72 | 6.88 | 15.82 |
| Efficiency & per share | |||||||
| Fixed asset turnover | 3.90 | 5.57 | 5.72 | 6.13 | 5.64 | 5.78 | 6.78 |
| Inventory turnover | 8.55 | 11.82 | 11.65 | 11.41 | 12.14 | 12.72 | 12.39 |
| Debtors turnover | 2.47 | 2.51 | 2.69 | 3.14 | 3.14 | 2.90 | 2.99 |
| EPS (βΉ) | 9.43 | 14.62 | 13.92 | 126.23 | 105.14 | 99.53 | 67.58 |
| Dividend per share (βΉ) | 1.25 | 1.50 | 1.50 | 12.50 | 10.00 | 10.00 | 6.00 |
| Book value per share (βΉ) | 94.75 | 86.61 | 73.25 | 604.43 | 542.41 | 446.66 | 347.44 |
Top companies in Water & Environmental Treatment Chemicals
3 companies that operate in the same segment as Labwater (Water & Environmental Treatment Chemicals) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Water heaters, purifiers, heat pumps, and softeners are manufactured and distributed by A.O. Smith. | 2006 | Bengaluru, Karnataka, India | USD 51.29 M | 408 | ||
Kitchen appliances manufacturing and sales in India. | 1955 | Pune, Maharashtra, India | USD 95.01 M | 468 | ||
Water soluble films and capsulated hygiene chemicals are manufactured. | 1992 | Mumbai, Maharashtra, India | USD 21.42 M | 40 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Labwater
Complete news archive for Labwater
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Labwater
Labwater is headquartered in India.
Labwater has 2,253 employees.
The primary company behind Labwater, Ion Exchange (India) Limited, reported revenue of βΉ3,003 Cr for FY 2026, up 6% year on year.
Ion Exchange (India) Ltd. specializes in water and environment management, providing purification systems for laboratories. They design, supply, and install technologies for pure and ultrapure water in biomedical, clinical, and industrial applications. Based in Mumbai, India, the company serves clients like IIT Roorkee and UAE institutions, ensuring compliance with international standards through innovative, cost-effective solutions.
Labwater offers Lab-Q Ultra, Lab-Q Smart, Lab-Q Water Maker, and Lab-Q Spectra.
Yes, Labwater is publicly traded on NSE under the ticker symbol IONEXCHANG.
Labwater operates through Ion Exchange (India) Limited.
The legal entities of Labwater currently have 12 directors, including Rajesh Chandrabhan Sharma, Aankur Patni, Dinesh Sharma and others.
Yes. Labwater publishes ZeroB Service App, with over 10,000 downloads.

